A vaccine that delivers rather than induces antibodies

Letvin, N. L.
November 2009
Gene Therapy;Nov2009, Vol. 16 Issue 11, p1283
Academic Journal
The article discusses on the use of a vaccine that delivers antibodies. It refers to a research study in which researchers examined a radically different approach to inducing long-term production of neutralizing antibodies against an AIDS virus. They used adeno-associated virus (AAV) to deliver, directly into the muscles of monkeys.


Related Articles

  • Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Baden, Lindsey R.; Karita, Etienne; Mutua, Gaudensia; Bekker, Linda-Gail; Gray, Glenda; Page-Shipp, Liesl; Walsh, Stephen R.; Nyombayire, Julien; Anzala, Omu; Roux, Surita; Laher, Fatima; Innes, Craig; Seaman, Michael S.; Cohen, Yehuda Z.; Peter, Lauren; Frahm, Nicole; McElrath, M. Juliana; Hayes, Peter; Swann, Edith; Grunenberg, Nicole // Annals of Internal Medicine;3/1/2016, Vol. 164 Issue 5, p313 

    Background: A prophylactic HIV-1 vaccine is a global health priority.Objective: To assess a novel vaccine platform as a prophylactic HIV-1 regimen.Design: Randomized, double-blind, placebo-controlled trial. Both participants and study personnel were blinded...

  • Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. Walsh, Stephen R.; Moodie, Zoe; Fiore-Gartland, Andrew J.; Morgan, Cecilia; Wilck, Marissa B.; Hammer, Scott M.; Buchbinder, Susan P.; Kalams, Spyros A.; Goepfert, Paul A.; Mulligan, Mark J.; Keefer, Michael C.; Baden, Lindsey R.; Swann, Edith M.; Grant, Shannon; Ahmed, Hasan; Fusheng Li; Hertz, Tomer; Self, Steven G.; Friedrich, David; Frahm, Nicole // Journal of Infectious Diseases;2/15/2016, Vol. 213 Issue 4, p541 

    Background: Increasing the breadth of human immunodeficiency virus type 1 (HIV-1) vaccine-elicited immune responses or targeting conserved regions may improve coverage of circulating strains. HIV Vaccine Trials Network 083 tested whether cellular immune responses with these features...

  • Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Oswald, Kelli; Shoemaker, Rebecca; Swanson, Tonya; Legasse, Alfred W.; Chiuchiolo, Maria J.; Parks, Christopher L.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Piatak, Michael; Lifson, Jeffrey D.; Picker, Louis J. // Nature;5/26/2011, Vol. 473 Issue 7348, p523 

    The acquired immunodeficiency syndrome (AIDS)-causing lentiviruses human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) effectively evade host immunity and, once established, infections with these viruses are only rarely controlled by immunological mechanisms. However, the...

  • OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma. Chunguang Li; Yan Yan; Weidan Ji; Longlong Bao; Haihua Qian; Lei Chen; Mengchao Wu; Hezhong Chen; Zhigang Li; Changqing Su // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: OCT4 and Survivin are important factors for cancer cell proliferation, renewal and dedifferentiation, and correlate with resistance to radiotherapy and chemotherapy in most human cancers, but their regulatory mechanisms are not well known. Methodology/Principal Findings: In this...

  • Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C. Alexander, Jeff; Mendy, Jason; Vang, Lo; Avanzini, Jenny B.; Garduno, Fermin; Manayani, Darly J.; Ishioka, Glenn; Farness, Peggy; Ping, Li-Hua; Swanstrom, Ronald; Parks, Robert; Liao, Hua-Xin; Haynes, Barton F.; Montefiori, David C.; LaBranche, Celia; Smith, Jonathan; Gurwith, Marc; Mayall, Tim // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background:There is a well-acknowledged need for an effective AIDS vaccine that protects against HIV-1 infection or limits invivo viral replication. The objective of these studies is to develop a replication-competent, vaccine vector based on the adenovirus serotype 4 (Ad4) virus expressing...

  • The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Nelson, Kenrad E.; Clements, Mary Lou; Miotti, Paolo; Cohn, Sylvia; Polk, Frank; Nelson, K E; Clements, M L; Miotti, P; Cohn, S; Polk, B F // Annals of Internal Medicine;9/1/88, Vol. 109 Issue 5, p383 

    Study Objective: To ascertain whether subjects infected with human immunodeficiency virus (HIV) generally develop protective hemagglutination inhibition antibody responses to inactivated influenza vaccines.Design: Prospective study of 104 persons before and after...

  • HIV: Neutralizing antibodies revisited. Bell, Elaine // Nature Reviews Immunology;Jun2002, Vol. 2 Issue 6, p387 

    Discusses research being done on the role of neutralizing antibodies in the development of HIV-1 vaccine. Reference to a study conducted by Maxine Moulard et al published in the 2002 issue of the 'Proceedings of the National Academy of Sciences.

  • Interactions Between Human Plasma Components and A Xenogenic Adenovirus Vector: Reduced Immunogenicity During Gene Transfer. Perreau, Matthieu; GuĂ©rin, Marie-Christine; Drouet, Christian; Kremer, Eric J. // Molecular Therapy;Nov2007, Vol. 15 Issue 11, p1998 

    By the time we are adolescents most of us have been in contact with several of the >50 human adenovirus (HAd) serotypes. These common subclinical infections lead to an efficient anti-adenovirus cross-reacting adaptive immunity. During gene therapy, the ubiquitous anti-adenovirus humoral response...

  • Modification of Adenovirus Gene Transfer Vectors With Synthetic Polymers: A Scientific Review and Technical Guide. Kreppel, Florian; Kochanek, Stefan // Molecular Therapy;Jan2008, Vol. 16 Issue 1, p16 

    The chemical modification of adenovirus (Ad) gene transfer vectors with synthetic polymers is a promising strategy for overcoming typical in vivo hurdles associated with Ad-mediated gene delivery. Polymer-modified Ad vectors induce significantly reduced innate immune responses, can evade...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics